Olema Pharmaceuticals, Inc.
Company Stats
- Market Cap
- $756.0M
- as of Sep 30, 2026
- Shares Outstanding
- 87.5M
- Free Float
- 64.9%
Income Statement
- Operating Income
- -$178.7M
- Net Income
- -$162.5M
- EBITDA
- -$178.2M
Balance Sheet
- Cash & Equivalents
- $48.3M
Returns & Capital
- SBC, 3Y Avg
- $19.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2024 | — | -$104.5M | — |
| FY2022 | — | -$82.4M | — |
| FY2021 | — | -$52.3M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 4, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges